tiprankstipranks
Trending News
More News >

Cleo Diagnostics Expands Ovarian Cancer Trial with Siles Health

Cleo Diagnostics Expands Ovarian Cancer Trial with Siles Health

CLEO Diagnostics Ltd (AU:COV) has released an update.

Confident Investing Starts Here:

Cleo Diagnostics Ltd is expanding its ovarian cancer trial with the inclusion of Siles Health, a leading women’s health specialist network in Australia. This collaboration aims to enhance clinical insights and support market adoption of CLEO’s innovative blood test for early ovarian cancer detection. By integrating Siles Health’s expertise, CLEO is poised to advance its trial strategy and increase market awareness for its potentially life-saving diagnostic tool.

For further insights into AU:COV stock, check out TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App